Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Npj Imaging|December 10, 2025
<sup>89</sup>Zr-anti-CD8 immunoPET visualizes heterogeneous intratumoral CD8<sup>+</sup> immune responses to treatment with radiation and anti-CTLA4Elizabeth A Germino, Kirstin A Zettlitz, Tyler Watkins, et al.Cancers|November 27, 2025
Comparative Evaluation of [<sup>68</sup>Ga]Ga-Fibroblast Activation Protein Inhibitor vs. [<sup>18</sup>F]FDG as a Novel Radiotracer for Biology-Guided Image RadiotherapyLin Qiu, Yue Chen, Trevor Ketcherside, et al.Biorxiv : the Preprint Server for Biology|August 8, 2025
Activation of IL-17+ ILC subsets in IL-18R-deficient mice during fungal allergen exposureAllyssa N Strohm, Blake Civello, Jana H Badrani, et al.Advances in Radiation Oncology|May 7, 2025
National Institutes of Health Funding to Support Radiation Oncology Research: A Comparative Trend Analysis Over a Decade, 2011-2021Amir Razavi, Michael K Rooney, Clifton D Fuller, et al.International Journal of Radiation Oncology, Biology, Physics|June 13, 2018
Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated SiteHeather M McGee, Megan E Daly, Sohelia Azghadi, et al.Nature Communications|July 30, 2022
RNA-binding protein RBM3 intrinsically suppresses lung innate lymphoid cell activation and inflammation partially through CysLT1RJana H Badrani, Allyssa N Strohm, Lee Lacasa, et al.Cancer Immunology Research|April 1, 2022
Hallmarks of Resistance to Immune-Checkpoint InhibitorsMaria Karasarides, Alexandria P Cogdill, Paul B Robbins, et al.Nature Communications|September 1, 2023
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trialArta M Monjazeb, Megan E Daly, Guillaume Luxardi, et al.Nature Communications|November 7, 2020
Publisher Correction: TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancerLaura Garcia Perez, Jan Kempski, Heather M McGee, et al.Nature Communications|May 27, 2020
TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancerLaura Garcia Perez, Jan Kempski, Heather M McGee, et al.Pageof 4